LRP1 and glioblastoma: Our results reveal that endocytosis plays an unexpected role in gefitinib action and that expression level of endocytosis proteins such as DNM2, LRP-1 or Rab5 could be relevant biomarkers to predict TKI efficiency in limiting dissemination of GBM cells from tumour spheroids.